Tasco Holdings (fka THII)

[JJdivini]

Tasco Holdings International Retains OTC Financial Network for Comprehensive Investor Relations CampaignadvertisementRelated information E-mail this article Print-friendly versionStocks mentioned in this articleTASCO HOLDINGS INTERNATIONAL INC(THII) Quote, Chart, News


All Business Wire NewsTasco Holdings International THII, a biotechnology company focused on stem cell cryogenics and disposable stem cell / tissue transfer instruments, announced today that it has retained OTC Financial Network, a division of National Financial Communications (NFC) Corporation, for a comprehensive investor relations campaign.


Related newsBio-Matrix Scientific Group Inc. Announces Completion Sale of Wholly Owned Subsidiary and Operating Entity to Tasco Holdings International, Inc.
NFC President Geoffrey Eiten said, "By developing or acquiring patented or proprietary technologies that can be converted into steady revenue streams, either by manufacturing products or licensing technology, Tasco Holdings is operating a unique business model that will allow for substantial growth over the near and long term."

Eiten continued, "Having recently purchased Bio-Matrix Scientific Group, an emerging leader in the stem cell storage and research segment of the $75 billion biotech and medical device industry, Tasco Holdings is uniquely situated for introduction to the financial community. We look forward to working with Tasco to expand its access to Wall Street and create market awareness for this emerging biotech leader."

Tasco Holdings Inc. recently acquired 100% of Bio-Matrix Scientific Group, a biotech research and development company focused on the growing, worldwide market for stem cell research service providers.

About Tasco Holdings International Inc.

Tasco Holdings Inc. recently purchased Bio-Matrix Scientific Group Inc. (www.BMXGonline.com), a biotech research and development Company that commercializes medical devices and monitoring systems for the growing, worldwide stem cell research market.

The Company aligns itself with strategic partners that offer key technologies in biomedical device development, tissue engineering, cell culturing, genome therapy and drug delivery systems to become a leading source for stem cell research technology and innovation and is building a state-of-the-art facility in San Diego, California, to cater to the growing stem cell research segment of the $75 billion biotechnology and medical device industry.

About OTC Financial Network

Since 1992, OTC Financial Network (www.otcfn.com) has provided consulting services and customized, proactive investor relations campaigns to more than 500 small/micro-cap public companies. The Company designs and implements results-driven direct mail, electronic marketing, shareholder communications and other programs to increase market awareness on behalf of its clients.

A partnership with OTC Financial Network can improve shareholder communications channels, facilitate capital formation opportunities, create an expanding and diversified base of institutional and retail shareholders, and garner media coverage. OTC Financial Network is a division of National Financial Communications Corp. based in Needham, MA. For more information visit www.otcfn.com and www.nationalfc.com.

Disclaimer: OTC Financial Network serves as special advisor to Tasco Holdings and has received fees for services, including $7500.00 per month paid by a third party, plus 200,000 options at an exercise price of $4.50 paid by the Company. These underlying securities have not been registered pursuant to the Securities Act of 1933, as amended (the "Securities Act"), and therefore may not be sold or transferred by Company except in the event that such shares are the subject of a registration statement. This is not an offer to buy or sell securities. Information or opinions in this release are presented solely for informative purposes, and are not intended nor should they be construed as investment advice. Additional compensation information and a full disclaimer can be found online by visiting http://www.otcfn.com/thii and selecting the "Disclaimer" link.